首页BOT • ASX
add
Botanix Pharmaceuticals Ltd
昨日收盘价
$0.049
当日价格范围
$0.045 - $0.049
年度波幅
$0.045 - $0.49
市值
1.02亿 AUD
平均交易量
1407.64万
市盈率
-
股息率
-
主要交易所
ASX
市场资讯
财务信息
损益表
收入
净收入
| (AUD) | 2025年12月info | 年同比变化 |
|---|---|---|
收入 | 825.29万 | 4,271.29% |
经营支出 | 2208.22万 | 41.82% |
净收入 | -1659.77万 | -7.47% |
净利润率 | -201.11 | 97.54% |
每股收益 | — | — |
息税折旧摊销前利润 | -1621.61万 | -5.12% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (AUD) | 2025年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 3161.25万 | -34.73% |
总资产 | 9857.31万 | -0.88% |
负债总额 | 4457.76万 | 540.50% |
权益总额 | 5399.55万 | — |
发行在外的股份 | 19.68亿 | — |
市净率 | 1.63 | — |
资产回报率 | -42.63% | — |
资本回报率 | -76.30% | — |
现金流
现金净变动
| (AUD) | 2025年12月info | 年同比变化 |
|---|---|---|
净收入 | -1659.77万 | -7.47% |
来自运营的现金 | -1513.52万 | 0.95% |
投资现金 | -22.08万 | 48.29% |
融资现金 | -127.75万 | -738.08% |
现金净变动 | -1667.70万 | -8.04% |
自由现金流 | -724.20万 | -58.36% |
简介
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
成立时间
1984
员工数量
11
